4580sek
-0,5 %
Date:2025-06-04Time:18:00:00Latest report:Q1-2025List:Mid CapTicker:FLERIE
Market Cap:3 575 msekEnterprise Value:2 774 msekNet Sales:0,10 msekEarnings:-329,5 msekEmployees:0ISIN:SE0022447348

Ratios

10-year key figure history for Flerie turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Flerie with index and moving average MA50 and MA200.

Stockprice:45,80
MA50:42,72
MA200:44,85
Price/MA200:2,1 %
RSI (14):62,9
Price/MA50:7,2 %

Description

Flerie is an active long-term life science investor with a focus on biotechnology and pharmaceutical investments globally. The company is based in Stockholm and London and manages a portfolio of investments in Europe, Israel and the USA. The main focus is on providing organizations that primarily operate in drug development with services and resources. Flerie was founded in 2011 and has its headquarters in Stockholm.

Pharmaceuticals